Is hantavirus important to practitioners?

Southern Medical Journal

Volumn 102, Issue 6, 2009, Pages 563-564

  Pierce Jr , J Rush ^a   Milton, J Scott ^b  

^a TTUHSC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

BUNYAVIRUS; CANADA; CAPILLARY LEAK SYNDROME; COUGHING; DIARRHEA; EDITORIAL; EXTRACORPOREAL OXYGENATION; FEVER; GASTROINTESTINAL DISEASE; GEOGRAPHIC DISTRIBUTION; GEOGRAPHY; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEADACHE; HEALTH CARE PERSONNEL; HEMORRHAGIC FEVER; HOST; HUMAN; IMMUNE RESPONSE; INHALATION; INTENSIVE CARE UNIT; MEDICAL PRACTICE; MORTALITY; NORTH AMERICA; PATHOGENESIS; PATIENT REFERRAL; PREVALENCE; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RURAL AREA; SEROTYPE; SOUTH AMERICA; SURVIVAL; TECHNOLOGY; THROMBOCYTOPENIA; UNITED STATES; URBAN AREA; VIROLOGY; VIRUS PARTICLE; VIRUS TRANSMISSION; VOMITING; ZOONOSIS;

HANTAVIRUS; HANTAVIRUS INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HUMANS; UNITED STATES;

EID: 68049103307     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181a4f49e     Document Type: Editorial

References (13)

1. Vinh DC, Embil JM. Hantavirus pulmonary syndrome: a concise clinical review. South Med J 2009;102:620-625.
2. Warner GS. Hantavirus illness in humans: review and update. South Med J 1996;89:264-271.
3. Mertz GJ, Hjelle B, Crowley M, et al. Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis 2006;19:437-442. (Pubitemid 44338102)
4. Chang B, Crowley M, Campen M, et al. Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med 2007;28:193-200.
5. Jonsson CB, Hooper J, Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res 2008;78:162-169.
6. Mertz GJ, Miedzinski L, Goade D, et al; Collaborative Antiviral Study Group. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004;39:1307-1313. (Pubitemid 39458516)
7. Rivers MN, Alexander JL, Rohde RE, et al. Hantavirus pulmonary syndrome in Texas: 1993-2006. South Med J. 2009;102:36-41.
8. Vitek CR, Ksiazek TG, Peters CJ, et al. Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. Clin Infect Dis 1996;23:283-285.
9. Zeitz PS, Graber JM, Voorhees RA, et al. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med 1997;39:463-467.
10. Fulhorst CF, Milazzo ML, Armstrong LR, et al. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure. Emerg Infect Dis 2007;13:532-538.
11. Dull SM, Brillman JC, Simpson SQ, et al. Hantavirus pulmonary syndrome: recognition and emergency department management. Ann Emerg Med 1994;24:530-536. (Pubitemid 24269951)
12. Alexander JL, Rivers MN, Rohde RE, et al. Two clusters of hantavirus infections in Texas [abstract]. Presented at 57th Annual James H. Steele Conference on Diseases in Nature Transmissible to Man. Austin, TX, June 12, 2007.
13. Sinclair JR, Carroll DS, Montgomery JM, et al. Two cases of hantavirus pulmonary syndrome in Randolph County, West Virginia: a coincidence of time and place? Am J Trop Med Hyg 2007;76:438-442. 909.